Inamasu J, Guiot B H
Department of Neurosurgery, University of South Florida College of Medicine, Harbourside Medical Tower Rm. 730, 4 Columbia Drive, Tampa, FL 33606, USA.
Minim Invasive Neurosurg. 2005 Dec;48(6):340-7. doi: 10.1055/s-2005-915634.
Laparoscopic anterior lumbar interbody fusion (LALIF) was first reported in 1995. It was expected to reduce the morbidity of an open ALIF, while maintaining its advantages. About a decade after its debut, the feasibility and short-term efficacy of the LALIF has been recognized. Currently, other minimally-invasive surgical options have been made available for the treatment of lumbar degenerative disc disease, and thus the role of LALIF has not been established in view of these other methods. The authors aim to clarify this, by conducting a review of the literature particularly on the outcome studies of LALIF. Several comparative studies showed that at the L5-S1 disc level, there was no marked difference between LALIF and the open or mini-open ALIF in terms of short-term efficacy, i. e., operative time, blood loss, and length of hospital stay. With regard to the complication rate, however, there was a higher incidence of retrograde ejaculation in LALIF. At the L4-L5 and L4-L5/L5-S1 disc levels, the complication rate and conversion rate to open surgery was high in LALIF, and many authors were not impressed with the LALIF at these levels. Several case series showed that the LALIF yielded excellent perioperative outcomes in the hands of experienced endoscopic spine surgeons at both the L5-S1 and L4-L5 disc levels. No conclusion regarding either the superiority or inferiority of LALIF to the open or mini-open ALIF can be drawn, because of the lack of data with a high-level of evidence. It cannot be denied, however, that some spine surgeons are abandoning this procedure and switching to the mini-open ALIF. Treatment of lumbar degenerative disc disease itself has been changing rapidly, as represented by the recent emergence of the lumbar artificial disc, and the future role of LALIF remains to be followed closely.
腹腔镜前路腰椎椎间融合术(LALIF)于1995年首次报道。人们期望它能降低开放性前路腰椎椎间融合术(ALIF)的发病率,同时保留其优势。在其首次亮相大约十年后,LALIF的可行性和短期疗效得到了认可。目前,已有其他微创手术方法可用于治疗腰椎间盘退变疾病,因此鉴于这些其他方法,LALIF的作用尚未明确。作者旨在通过对文献进行综述,特别是对LALIF的疗效研究进行综述来阐明这一点。几项比较研究表明,在L5-S1椎间盘水平,LALIF与开放性或mini-open ALIF在短期疗效方面,即手术时间、失血量和住院时间方面,没有显著差异。然而,就并发症发生率而言,LALIF中逆行射精的发生率较高。在L4-L5和L4-L5/L5-S1椎间盘水平,LALIF的并发症发生率和转为开放手术的转化率较高,许多作者对这些水平的LALIF并不看好。几个病例系列表明,在经验丰富的内镜脊柱外科医生手中,LALIF在L5-S1和L4-L5椎间盘水平均产生了出色的围手术期效果。由于缺乏高水平证据的数据,无法得出LALIF优于或劣于开放性或mini-open ALIF的结论。然而,不可否认的是,一些脊柱外科医生正在放弃这种手术,转而采用mini-open ALIF。腰椎间盘退变疾病的治疗本身一直在迅速变化,以最近出现的腰椎人工椎间盘为代表,LALIF的未来作用仍有待密切关注。